Media Healthcare Sector

Xencor

Market Cap: US$537.3m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.

Arvinas

Market Cap: US$531.7m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

Relay Therapeutics

Market Cap: US$528.1m

Operates as a clinical-stage precision medicines company.

Enhabit

Market Cap: US$524.6m

Provides home health and hospice services in the United States.

Taysha Gene Therapies

Market Cap: US$523.8m

A clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system.

LifeMD

Market Cap: US$521.3m

Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.

Bicara Therapeutics

Market Cap: US$515.9m

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

Stoke Therapeutics

Market Cap: US$514.8m

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

Sana Biotechnology

Market Cap: US$512.0m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

OrthoPediatrics

Market Cap: US$506.3m

A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.

Community Health Systems

Market Cap: US$504.2m

Owns, leases, and operates general acute care hospitals in the United States.

Maze Therapeutics

Market Cap: US$502.8m

A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.

Owens & Minor

Market Cap: US$499.5m

Operates as a healthcare solutions company worldwide.

Axogen

Market Cap: US$499.2m

Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.

Upstream Bio

Market Cap: US$496.0m

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

Talkspace

Market Cap: US$495.3m

Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.

Virtus Health

Market Cap: AU$705.2m

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.

EyePoint Pharmaceuticals

Market Cap: US$484.4m

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

Kura Oncology

Market Cap: US$480.5m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Auna

Market Cap: US$478.6m

A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.

Tyra Biosciences

Market Cap: US$478.1m

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

Opthea

Market Cap: AU$738.8m

A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.

Definitive Healthcare

Market Cap: US$475.6m

Provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.

Botanix Pharmaceuticals

Market Cap: AU$735.3m

Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.

Castle Biosciences

Market Cap: US$468.6m

A molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma, and mental health conditions.

SBC Medical Group Holdings

Market Cap: US$466.3m

Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.

Autolus Therapeutics

Market Cap: US$465.7m

A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.

Atai Life Sciences

Market Cap: US$462.8m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

Cullinan Therapeutics

Market Cap: US$462.7m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

Oxford Biomedica

Market Cap: UK£342.4m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Capricor Therapeutics

Market Cap: US$461.2m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Semler Scientific

Market Cap: US$460.8m

Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.

Theravance Biopharma

Market Cap: US$457.5m

A biopharmaceutical company, develops and commercializes of medicines in the United States.

Zevra Therapeutics

Market Cap: US$455.5m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

PYC Therapeutics

Market Cap: AU$699.9m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Savara

Market Cap: US$449.8m

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.